Effect of gemfibrozil on serum lipid levels

A short term investigation of the effect of Gemfibrozil in 1200 mg daily doses has been carried out in a group of 20 Swedish males, 9 Lp[a+] and 11 Lp[a-]. The effect of 8 weeks of treatment upon serum lipids resembled those found in previous trials, with a significant decrease in serum total cholesterol. In this series, even VLDL cholesterol and apoB levels decreased significantly. With the apparent exception of HDL cholesterol, there was no suggestion that Lp[a+] individuals responded less well to treatment than did Lp[a-] individuals.